M. Ahmar, S. Thomé, B. Cazes
FULL PAPER
(300 MHz, CDCl3): δ = 6.73 [s, 1 H, CH=C(C=O)], 3.21 [dd (tapp),
HaHb], 2.44 [d, 2J = 19.2 Hz, 1 H, (C=O)HaHb], 2.09 (s, 3 H, CH3),
1.45 (s, 3 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 204.1
(C=O), 170.5 (C=O), 158.3 (C-3), 139.4 (C-2), 69.7 (Cq–O), 65.8
2
2
2J = 6.0, J = 5.8 Hz, 1 H, (C-4)-O-CH], 2.63 [d, J = 19.2 Hz, 1
2
H, (C=O)CHaHb], 2.46 [d, J = 19.2 Hz, 1 H, (C=O)CHaHb], 2.21
[t, 3J = 7.5 Hz, 2 H, (C-2)CH2], 1.60–1.45 (m, 2 H, O–CHCH2), (Cq–O), 63.7 (CH2–OAc), 38.6 [(C=O)CH2], 20.8 (CH3), 18.5
3
1.52 [quint, J = 7.5 Hz, 2 H, (C-2)CH2CH2], 1.45–1.15 (m, 10 H,
(CH3) ppm.
3
3
4ϫ CH2), 0.94 (t, J = 7.3 Hz, 3 H, CH3), 0.89 (t, J = 6.8 Hz, 3
H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 205.0 (C=O),
154.7 (C-3), 151.0 (C-2), 64.6 (C-4, Cq-O-CH), 63.1 [(C-4)-O-CH],
38.0 [(C=O)CH2], 31.8, 30.9, 29.2, 26.9, 26.2, 22.6 and 20.8 (7ϫ
3
Isomer (minor) cis-7j: 1H NMR (300 MHz, CDCl3): δ = 7.29 [d, J
= 5.8 Hz, 1 H, HC=CH(C=O)], 6.46 [d, 3J = 5.8 Hz, 1 H,
HC=CH(C=O)], 4.14 (d, 2J = 12.5 Hz, 1 H, HaHbC–OAc), 4.09
(d,2J=12.5 Hz,1H,HaHbC–OAc),2.71[d,2J=19.2 Hz,1H,(C=O)-
HaHb], 2.47 [d, 2J = 19.2 Hz, 1 H, (C=O)HaHb], 2.09 (s, 3 H, CH3),
1.49 (s, 3 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 204.1
(C=O), 170.6 (C=O), 158.4 (C-3), 139.5 (C-2), 69.4 (Cq–O), 67.3
(Cq–O), 63.9 (CH2–OAc), 38.1 [(C=O)CH2], 20.8 (CH3), 16.2
(CH3) ppm.
CH ), 14.2 and 14.0 (2ϫ CH ) ppm. IR (thin film): ν = 2958, 2927,
˜
2
3
2858, 1714 (CO), 1458, 1379, 1254, 1045, 968 cm–1. HRMS (CI):
calcd. for C15H25O2: [M + H]+ 237.1855; found 237.1853.
Spiroepoxycyclopentenone cis-7h: Epoxidation of cyclopentenone
(Z)-4h (230 mg, 1.05 mmol) by the General Procedure (Table 1, En-
try 9) gave cis-7h (177.4 mg, 72%) after flash chromatography (PE/
Et2O 80:20). Yellow oil; Rf = 0.36 (PE/Et2O 70:30). 1H NMR
Spiroepoxycyclopentenone (7k): Epoxidation of cyclopentenone (E
+ Z)-4k (220 mg, 1.22 mmol) by the General Procedure (Table 2,
Entry 2) gave (trans + cis)-7k (157 mg, 66%, trans/cis = 80:20) after
flash chromatography (PE/Et2O 80:20.
4
(300 MHz, CDCl3): δ = 6.85 [d, J = 1.2 Hz, 1 H, CH=C(C=O)],
3.36 [dd (tapp), 2J = 6.2, 2J = 6.0 Hz, 1 H, O–CH], 2.69 [d, 2J =
2
19.2 Hz, 1 H, (C=O)CHaHb], 2.58 [d, J = 19.2 Hz, 1 H, (C=O)-
3
4
Isomers (trans + cis)-7k: Rf = 0.21 (PE/Et2O 80:20). IR (thin film):
CHaHb], 2.24 [td, J = 7.5, J = 1.2 Hz, 2 H, (C-2)CH2], 1.80–1.60
ν = 2955, 2884, 1719 (C=O), 1350, 1248, 1118, 1165, 969, 840 cm–1.
(m, 2 H, O–CHCH2), 1.53 [quint, 3J = 7.5 Hz, 2 H, (C-2)CH2CH2],
˜
3
Isomer (major) trans-7k: 1H NMR (300 MHz, CDCl3): δ = 7.13
[d, 3J = 5.7 Hz, 1 H, CH=CH(C=O)], 6.31 [d, 3J = 5.7 Hz, 1 H,
1.60–1.20 (m, 8 H, 4ϫ CH2), 0.94 (t, J = 7.5 Hz, 3 H, CH3), 0.89
(t, J = 6.8 Hz, 3 H, CH3) ppm. 13C NMR (75 MHz, CDCl3): δ =
3
3
204.5 (C=O), 154.2 (C-3), 150.8 (C-2), 64.4 (C-4, Cq-O-CH), 65.3
[(C-4)-O-CH], 39.8 [(C=O)CH2], 32.2, 30.9, 29.1, 26.3, 25.2, 22.6
and 20.8 (7ϫ CH2), 14.1 and 13.9 (2ϫ CH3) ppm. IR (thin film):
CH=CH(C=O)], 3.31 (tapp, Japp = 6.8 Hz, 1 H, O-CH-CHaHbSi),
2
2
2.53 [d, J = 19.2 Hz, 1 H, (C=O)CHaHb], 2.37 [d, J = 19.2 Hz, 1
H, (C=O)CHaHb], 0.97 (dd, 2J = 14.5, 3J = 6.6 Hz, 1 H, CHaHbSi),
2
3
ν = 2958, 2928, 2858, 1707 (C=O), 1457, 1387, 1267, 1228, 1082,
˜
0.83 (dd, J = 14.5, J = 6.8 Hz, 1 H, CHaHbSi), 0.06 (s, 9 H, 3ϫ
SiCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 205.1 (C=O), 162.5
(C-3), 137.7 (C-2), 66.6 (C-4, Cq-O-CH), 61.5 (O-CH-CH2Si), 37.5
[(C=O)CH2], 18.9 [CH2Si(CH3)3], –1.1 (3ϫ SiCH3) ppm.
960, 812 cm–1. MS (CI): m/z (%) = 237 (100) [M + H]+, 222 (11),
208 (41), 190 (47).
Spiroepoxycyclopentenone 9h: Epoxidation of cyclopentenone 5h
(221 mg, 0.93 mmol) by the General Procedure (Table 1, Entry 10)
gave a mixture of trans-9h and cis-9h (112 mg, 47%, trans-9h/cis-
9h 90:10) after flash chromatography (PE/Et2O 95:5).
Isomer (minor) cis-7k: 1H NMR (300 MHz, CDCl3): δ = 7.26 [d,
3J = 5.8 Hz, 1 H, CH=CH(CO)], 6.43 [d, 3J = 5.8 Hz, 1 H,
CH=CH(C=O)], 3.46 (m, 1 H, O-CH-CH2Si), 2.62 [d, 2J =
2
19.2 Hz, 1 H, (C=O)CHaHb], 2.51 [d, J = 19.2 Hz, 1 H, (C=O)-
Isomers (trans + cis)-9h: Yellow oil; Rf = 0.34 (PE/Et2O 90:10). IR
CHaHb], 1.10–1.25 (m, 2 H, CH2Si), 0.06 (s, 9 H, 3ϫ SiCH3) ppm.
13C NMR (75 MHz, CDCl3): δ = 204.9 (C=O), 159.4 (C-3), 139.2
(C-2), 65.9 (C-4, Cq-O-CH), 62.6 (O-CH-CH2Si), 40.9 [(C=O)-
CH2], 17.5 [CH2Si(CH3)3], –1.1 (3ϫ SiCH3) ppm. MS (CI): m/z
(%) = 197 (100) [M + H]+, 154 (9), 125 (7), 107 (18), 81 (25), 69
(36). HRMS (CI): calcd. for C10H17O2Si: [M + H]+ 197.0998; found
197.1009.
(thin film): ν = 2960, 2930, 2860, 1700 (C=O), 1460, 1386, 1270,
˜
1229, 1082, 960, 812 cm–1.
Isomer trans-9h: 1H NMR (300 MHz, CDCl3): δ = 6.70 [s, 1 H,
CH=C(C=O)], 3.29 [d, 2J = 4.3 Hz, 1 H, (C-4)-O-CHaHb], 3.09
[d,2J=4.3 Hz,1H,(C-4)-O-CHaHb],2.53[t, 3J=5.3 Hz,1H,(C=O)-
CH], 2.23 [t, 3J = 6.8 Hz, 2 H, (C-2)CH2], 1.51 [m, 2 H, (C-2)-
3
CH2CH2], 1.2–1.4 (m, 10 H, 5ϫ CH2), 0.96 (t, J = 7.3 Hz, CH3),
Spiroepoxycyclopentenone 7l: Epoxidation of cyclopentenone (E +
Z)-4l (180.4 mg, 1 mmol) by the General Procedure (Table 2, En-
try 3) gave (trans + cis)-7l (162 mg, 82%, trans/cis = 64:36) after
flash chromatography (PE/Et2O 80:20).
0.84 (t, 3J = 6.8 Hz, 3 H, CH3) ppm. 13C NMR (75 MHz, CDCl3):
δ = 207.3 (C=O), 153.1 (C-3), 151.6 (C-2), 64.8 (C-4, Cq–O), 51.8
[(C-4)-O-CH2], 48.4 [(C=O)CH], 31.7 [(C-2)CH2], 31.7, 29.7, 27.1,
26.0, 22.8 and 20.9 (6ϫ CH2), 14.2 and 14.0 (2ϫ CH3) ppm.
Isomers (trans + cis)-7l: Rf = 0.46 (PE/Et2O 80:20).
Isomer cis-9h: 1H NMR (300 MHz, CDCl3): δ = 6.92 (s, 1 H,
CH=CCO), 3.29 [d, 2J = 4.3 Hz, 1 H, (C-4)-O-CHaHb], 3.08 [d, J Isomer (major) trans-7l: H NMR (300 MHz, CDCl3): δ = 7.43 [d,
2
1
3
= 4.3 Hz, 1 H, (C-4)-O-CHaHb], 2.44 [t, J = 5.3 Hz, 1 H, (C=O)-
3J = 5.9 Hz, 1 H, HC=CH(C=O)], 6.63 [d, 3J = 5.9 Hz, 1 H,
CH=CH(C=O)], 2.63 [d, 2J = 19.0 Hz, 1 H, (C=O)CHaHb], 2.45
[d, 2J = 19.0 Hz, 1 H, (C=O)CHaHb], 1.40 (s, 3 H, O–CCH3), 0.14
(s, 9 H, 3ϫ SiCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 205.3
(C=O), 161.2 (C-3), 138.0 (C-2), 68.3 (C-4, Cq–O), 62.0 (O-C-Si),
40.4 [(C=O)CH2], 17.1 (O-CCH3), –2.6 (3ϫ SiCH3) ppm.
CH], 2.22 [t, 3J = 6.8 Hz, 2 H, (C-2)CH2], 1.50 [m, 2 H, (C-2)-
3
CH2CH2], 1.2–1.4 (m, 10 H, 5ϫ CH2), 1.25 (t, J = 7.3 Hz, CH3),
3
0.85 (t, J = 6.8 Hz, CH3) ppm.
Spiroepoxycyclopentenone 7j: Epoxidation of cyclopentenone (E +
Z)-4j (160 mg, 0.89 mmol) by the General Procedure (Table 2, En-
try 1) gave (trans + cis)-7j (117 mg, 67%, trans/cis 53:46) after flash
chromatography (PE/Et2O 80:20).
Isomer (minor) cis-7l: 1H NMR (300 MHz, CDCl3): δ = 7.30 [d, J
3
= 5.9 Hz, 1 H, HC=CH(C=O)], 6.34 [d, 3J = 5.9 Hz, 1 H,
2
C=CH(C=O)], 2.68 [d, J = 19.0 Hz, 1 H, (C=O)CHaHb], 2.46 [d,
Isomers (trans + cis)-7j: Yellow oil; Rf = 0.24 (PE/Et2O 70:30).
2J = 19.0 Hz, 1 H, (C=O)CHaHb], 1.33 (s, 3 H, OCCH3), 0.18 (s,
1
Isomer (major) trans-7j: H NMR (300 MHz, CDCl3): δ = 7.34 [d, 9 H, 3ϫ SiCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 205.13
3J = 6.0 Hz, 1 H, HC=CH(C=O)], 6.43 [d, 3J = 6.0 Hz, 1 H,
HC=CH(C=O)], 4.27 (d, 2J = 12.0 Hz, 1 H, HaHbC–OAc), 4.20 (d, [(C=O)CH2], 20.3 (O–CCH3), –1.9 (3ϫ SiCH3) ppm. GC–MS (EI):
2J = 12.0 Hz, 1 H, HaHbC–OAc), 2.67 [d, 2J = 19.2 Hz,1 H, (C=O)- m/z (%) = 196 (6) [M]+, 181 (5), 154 (4), 153 (11), 116 (4), 101 (4),
(C=O), 161.7 (C-3), 137.4 (C-2), 66.6 (C-4), 61.6 (O-C-Si), 38.8
7102
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 7093–7105